
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol. , 17 February 2023
Sec. Cancer Imaging and Image-directed Interventions
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1095362
A retraction of this article was approved in:
Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis
Citation: Shen F, Li J, Liu F, Sun N, Qiu X, Ding W and Sun X (2023) The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis. Front. Oncol. 13:1095362. doi: 10.3389/fonc.2023.1095362
Received: 11 November 2022; Accepted: 19 January 2023;
Published: 17 February 2023; Retracted: 20 February 2024.
Edited by:
Min Tang, Jiangsu University, ChinaReviewed by:
Chen Li, Free University of Berlin, GermanyDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.